Summit Global Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.64M Buy
14,214
+10,935
+333% +$2.03M 0.16% 94
2025
Q1
$687K Sell
3,279
-9,986
-75% -$2.09M 0.05% 244
2024
Q4
$2.36M Buy
13,265
+1,619
+14% +$288K 0.15% 118
2024
Q3
$2.3M Sell
11,646
-1,232
-10% -$243K 0.15% 120
2024
Q2
$2.21M Sell
12,878
-2,243
-15% -$385K 0.15% 124
2024
Q1
$2.75M Sell
15,121
-42,935
-74% -$7.82M 0.2% 93
2023
Q4
$9M Sell
58,056
-6,530
-10% -$1.01M 0.59% 35
2023
Q3
$9.63M Buy
64,586
+1,389
+2% +$207K 0.64% 37
2023
Q2
$8.52M Buy
63,197
+45,677
+261% +$6.15M 0.56% 41
2023
Q1
$2.79M Sell
17,520
-40,240
-70% -$6.41M 0.22% 111
2022
Q4
$9.34M Sell
57,760
-1,082
-2% -$175K 0.79% 28
2022
Q3
$7.9M Buy
58,842
+259
+0.4% +$34.8K 0.73% 33
2022
Q2
$8.97M Sell
58,583
-64,222
-52% -$9.84M 0.79% 34
2022
Q1
$19.9M Buy
122,805
+79,584
+184% +$12.9M 1.47% 12
2021
Q4
$5.85M Buy
43,221
+6,110
+16% +$827K 0.38% 64
2021
Q3
$4M Sell
37,111
-2,443
-6% -$264K 0.3% 75
2021
Q2
$4.45M Sell
39,554
-967
-2% -$109K 0.27% 77
2021
Q1
$4.39M Buy
40,521
+486
+1% +$52.6K 0.28% 68
2020
Q4
$4.29M Buy
40,035
+6,410
+19% +$687K 0.43% 57
2020
Q3
$2.95M Sell
33,625
-1,397
-4% -$122K 0.3% 60
2020
Q2
$3.44M Buy
35,022
+15,468
+79% +$1.52M 0.4% 47
2020
Q1
$1.49M Sell
19,554
-84,898
-81% -$6.47M 0.22% 62
2019
Q4
$9.25M Buy
104,452
+1,148
+1% +$102K 1% 36
2019
Q3
$7.82M Sell
103,304
-119,855
-54% -$9.08M 0.91% 41
2019
Q2
$16.2M Buy
223,159
+103,471
+86% +$7.52M 2.04% 7
2019
Q1
$9.65M Buy
+119,688
New +$9.65M 1.23% 25
2018
Q4
Sell
-2,327
Closed -$220K 251
2018
Q3
$220K Sell
2,327
-200
-8% -$18.9K 0.03% 244
2018
Q2
$234K Sell
2,527
-49,787
-95% -$4.61M 0.04% 244
2018
Q1
$4.95M Buy
52,314
+14,689
+39% +$1.39M 0.79% 41
2017
Q4
$3.64M Buy
+37,625
New +$3.64M 0.56% 48